Department of Pharmacy, Wuhan Hankou Hospital, Wuhan, China.
Department of Pediatric Gastroenterology, The First Hospital of Jilin University, Changchun, China.
Pharmazie. 2020 Sep 1;75(9):430-435. doi: 10.1691/ph.2020.0497.
Ischemia/reperfusion (I/R) cause secondary myocardial damage following a blood reflow after myocardial infarction. This study aimed to explore oxycodone as a myocardial protector after an I/R injury in rats. Oxycodone reduced myocardial infarction volume, an I/R-induced apoptosis of the cardiomyocytes, the serum levels of CK-MB and LDH. The ejection fraction and fraction shortening in the I/R rats also increased. From the molecular mechanism, it was evident that oxycodone not only decreased the expression levels of Bax, active-caspase 3 protein but also increased the expression levels of Bcl2, p-PI3K, and p-Akt protein in heart tissue of the I/R rats. , oxycodone induced anti-H9c2 cell apoptosis after hypoxia/reoxygenation (H/R). However, its ability to act as a myocardial protector deteriorated in the presence of a PI3K/Akt pathway inhibitor.
缺血/再灌注(I/R)会在心肌梗死后血液再流时引起继发性心肌损伤。本研究旨在探讨羟考酮在大鼠 I/R 损伤后作为心肌保护剂的作用。羟考酮减少了心肌梗死面积、I/R 诱导的心肌细胞凋亡、血清肌酸激酶同工酶(CK-MB)和乳酸脱氢酶(LDH)水平。I/R 大鼠的射血分数和短轴缩短率也增加了。从分子机制上看,羟考酮不仅降低了 Bax、活性 caspase-3 蛋白的表达水平,还增加了心脏组织中 Bcl2、p-PI3K 和 p-Akt 蛋白的表达水平。此外,羟考酮在缺氧/复氧(H/R)后诱导 H9c2 细胞凋亡,但在存在 PI3K/Akt 通路抑制剂的情况下,其作为心肌保护剂的能力恶化。